Safety and Tolerability
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
4TEEN4 PharmaceuticalsAK1967
AlumisExperimental drug: ESK-001
Clinical Trials (2)
Total enrollment: 49 patients across 2 trials
Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)
Start: Mar 2024Est. completion: Sep 2024
Phase 1Completed
Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants
Start: May 2022Est. completion: Dec 202249 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space